Annual sales fell from KRW 62.6 billion in 2022 to KRW 51 billion in 2023 (down 18.5% year on year), then rose to KRW 69.8 billion in 2024 (up 36.9%), which was the largest year in 2022–2025. Sales of KRW 50.9 billion in 2025 (down 27.0%) made it the smallest year in the period.
Operating losses of KRW 3.18 billion in 2022 and KRW 3.54 billion in 2023 were followed by an operating profit of KRW 1.62 billion in 2024, which turned into an operating loss of KRW 1.72 billion in 2025. Operating margins were -5.1% in 2022, -6.9% in 2023, 2.3% in 2024 and -3.4% in 2025.
Net loss attributable to controlling shareholders was KRW 5.61 billion in 2022 and KRW 3.29 billion in 2023, turned into a profit of KRW 2.48 billion in 2024, and returned to a loss of KRW 4.65 billion in 2025.
Net income including non-controlling interests moved in the same direction, with a net loss of KRW 4.65 billion in 2025. The company cited lower cosmetics sales and goodwill impairment for the 2025 swing, and the impairment can be read as a one-time charge.
Operating cash flow was -KRW 2.13 billion in 2025, after KRW 1.47 billion in 2024. On a quarterly basis, an operating loss of KRW 495 million in Q3 2025 was followed by KRW 81.37 million in Q4 2025, KRW 668 million in Q1 2026, KRW 805 million in Q2 2026 and KRW 461 million in Q3 2026.
The Q3 2026 operating loss was smaller than both the prior quarter and the same quarter a year earlier. The controlling-shareholder net loss was largest in Q4 2025 at KRW 4.34 billion, while the KRW 1.04 billion loss in Q3 2026 widened from a year earlier.
According to WiseReport data as of September 7, 2026, half-year 2026 standalone sales fell 11.2% year on year, the operating loss rose 28.8%, and net income swung to a loss.
Quarterly sales bottomed at KRW 10.1 billion in Q1 2026 and recovered in Q2 and Q3, but the operating loss did not shrink much alongside the sales recovery.